Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05563467
Title Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma. (PEMBR-01)
Acronym PEMBR-01
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Maria Sklodowska-Curie National Research Institute of Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL

Facility Status City State Zip Country Details
Maria Sklodowska-Curie National Research Institute of Oncology RECRUITING Gliwice Śląskie 44-102 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field